Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'paroxetine' OR with Authors including 'paroxetine' OR with Abstract including 'paroxetine' OR with Keywords including 'paroxetine'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Battaglia G, Yeh SY, O'He... 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine de... J Pharmacol Exp Ther 1987
Hekmatpanah CR, McKenna D... Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced n... Neurosci Lett 1989
Johnson MP, Nichols DE Neurotoxic effects of the alpha-ethyl homologue of MDMA following suba... Pharmacol Biochem Be... 1989
Hashimoto K, Goromaru T Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-m... Neuropharmacology 1990
Hekmatpanah CR, Peroutka ... 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-... Eur J Pharmacol 1990
Johnson MP, Huang XM, Obe... Behavioral, biochemical and neurotoxicological actions of the alpha-et... Eur J Pharmacol 1990
Nichols DE, Brewster WK, ... Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amph... J Med Chem 1990
Scheffel U, Ricaurte GA Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamin... Brain Res 1990
Winslow JT, Insel TR Serotonergic modulation of rat pup ultrasonic vocal development: studi... J Pharmacol Exp Ther 1990
McKenna DJ, Guan XM, Shul... 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... Pharmacol Biochem Be... 1991
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Battaglia G, Sharkey J, K... Neuroanatomic specificity and time course of alterations in rat brain ... Synapse 1991
Huang XM, Johnson MP, Nic... Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase) Eur J Pharmacol 1991
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Johnson MP, Huang XM, Nic... Serotonin neurotoxicity in rats after combined treatment with a dopami... Pharmacol Biochem Be... 1991
Millan MJ, Colpaert FC Methylenedioxymethamphetamine induces spontaneous tail-flicks in the r... Eur J Pharmacol 1991
Nash JF, Arora RC, Schrei... Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding ... Biochem Pharmacol 1991
Sharkey J, McBean DE, Kel... Alterations in hippocampal function following repeated exposure to the... Psychopharmacology (... 1991
Hashimoto K, Maeda H, Gor... Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity ... Eur J Pharmacol 1992
Lehmann J, DeSouza EB, Cu... Regional distribution to recovery of 5-HT levels after administration ... Ann N Y Acad Sci 1992
McCann UD, Ricaurte GA MDMA ('ecstasy') and panic disorder: induction by a single dose Biol Psychiatry 1992
Ricaurte GA, Martello AL,... Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on ce... J Pharmacol Exp Ther 1992
Steele TD, Katz JL, Ricau... Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-amin... Brain Res 1992
Hashimoto K, Maeda H, Hir... Drug effects on distribution of [3H]3,4-methylenedioxymethamphetamine ... Eur J Pharmacol 1993
Huang X, Nichols DE 5-HT2 receptor-mediated potentiation of dopamine synthesis and central... Eur J Pharmacol 1993
Scanzello CR, Hatzidimitr... Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine ... J Pharmacol Exp Ther 1993
Hewitt KE, Green AR Chlormethiazole, dizocilpine and haloperidol prevent the degeneration ... Neuropharmacology 1994
Marona-Lewicka D, Nichols... Behavioral effects of the highly selective serotonin releasing agent 5... Eur J Pharmacol 1994
Scheffel U, Dannals RF, S... Development of PET/SPECT ligands for the serotonin transporter NIDA Res Monogr 1994
Sprague JE, Huang X, Kant... Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurot... Life Sci 1994
Skop BP, Finkelstein JA, ... The serotonin syndrome associated with paroxetine, an over-the-counter... Am J Emerg Med 1994
Aguirre N, Galbete JL, La... Methylenedioxymethamphetamine induces opposite changes in central pre-... Eur J Pharmacol 1995
Colado MI, Green AR The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecst... Eur J Pharmacol 1995
Colado MI, Williams JL, G... The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 me... Br J Pharmacol 1995
Sprague JE, Nichols DE The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-meth... J Pharmacol Exp Ther 1995
Sprague JE, Nichols DE Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the... Psychopharmacology (... 1995
Sprague JE, Johnson MP, S... Studies on the mechanism of p-chloroamphetamine neurotoxicity Biochem Pharmacol 1996
Murray TK, Williams JL, M... The spin trap reagent PBN attenuates degeneration of 5-HT neurones in ... Neuropharmacology 1996
Bonson KR, Buckholtz JW, ... Chronic administration of serotonergic antidepressants attenuates the ... Neuropsychopharmacol... 1996
Colado MI, O'Shea E, Gran... In vivo evidence for free radical involvement in the degeneration of r... Br J Pharmacol 1997
Colado MI, Granados R, O'... Role of hyperthermia in the protective action of clomethiazole against... Br J Pharmacol 1998
Windhaber J, Maierhofer D... Panic disorder induced by large doses of 3,4-methylenedioxymethampheta... J Clin Psychopharmac... 1998
Aguirre N, Barrionuevo M,... The role of dopaminergic systems in the perinatal sensitivity to 3, 4-... J Pharmacol Exp Ther 1998
O'Shea E, Granados R, Est... The relationship between the degree of neurodegeneration of rat brain ... Neuropharmacology 1998
Obradovic T, Imel KM, Whi... Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucle... Brain Res 1998
Obradovic T, Imel KM, Whi... Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucle... Brain Res 1998
Yeh SY N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxyme... Synapse 1999
Yeh SY, Dersch C, Rothman... Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induce... Synapse 1999
Colado MI, Granados R, O'... The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, 'e... Pharmacol Toxicol 1999
Colado MI, Esteban B, O'S... Studies on the neuroprotective effect of pentobarbitone on MDMA-induce... Psychopharmacology (... 1999
Mortensen OV, Kristensen ... Molecular cloning, expression and characterization of a bovine seroton... Brain Res Mol Brain ... 1999
Aguirre N, Barrionuevo M,... Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-i... Neuroreport 1999
Edwards JG, Anderson I Systematic review and guide to selection of selective serotonin reupta... Drugs 1999
Russell BR, Laverty R Correlation between 5-HT content and uptake site density following (S)... Ann N Y Acad Sci 2000
Shirayama Y, Hashimoto K,... 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA i... Eur J Pharmacol 2000
Sanchez V, Camarero J, Es... The mechanisms involved in the long-lasting neuroprotective effect of ... Br J Pharmacol 2001
Colado MI, O'Shea E, Este... Studies on the neuroprotective effect of the enantiomers of AR-A008055... Psychopharmacology (... 2001
Connor TJ, Dennedy MC, Ha... Methylenedioxymethamphetamine-induced suppression of interleukin-1beta... Eur J Pharmacol 2001
Mamamoorthy Y, Tyndale R,... Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic a... Pharmacogenetics 2001
O'Loinsigh ED, Boland G, ... Behavioural, hyperthermic and neurotoxic effects of 3,4- methylenediox... Prog Neuropsychophar... 2001
Mortensen OV, Kristensen ... Species-scanning mutagenesis of the serotonin transporter reveals resi... J Neurochem 2001
Ramamoorthy Y, Tyndale RF... Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic a... Pharmacogenetics 2001
Farré M, Roset PN, de la ... Interaction of Paroxetine and MDMA in humans College on Problems... 2002
Fone KF, Beckett SG, Toph... Long-term changes in social interaction and reward following repeated ... Psychopharmacology (... 2002
Szabo Z, McCann UD, Wilso... Comparison of (+)-(11)C-McN5652 and (11)C-DASB as Serotonin Transporte... J Nucl Med 2002
O'Shea E, Easton N, Fry J... Protection against 3,4-methylenedioxymethamphetamine-induced neurodege... J Neurochem 2002
Ramamoorthy Y, Yu A, Suh ... Reduced (+/-)-3,4-methylenedioxymethamphetamine ('Ecstasy') metabolism... Biochem Pharmacol 2002
Fernandez F, Aguerre S, M... Influences of the corticotropic axis and sympathetic activity on neuro... Eur J Neurosci 2002
Sanchez V, Camarero J, O\... Differential effect of dietary selenium on the long-term neurotoxicity... Neuropharmacology 2003
Bull EJ, Hutson PH, Fone ... Reduced social interaction following 3,4-methylenedioxymethamphetamine... Neuropharmacology 2003
Bogen IL, Haug KH, Myhre ... Short- and long-term effects of MDMA ("ecstasy") on synaptosomal and v... Neurochem Int 2003
Wang JS, DeVane CL Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- an... Drug Metab Dispos 2003
Pacifici R, Pichini S, Zu... Paroxetine Inhibits Acute Effects of MDMA on the Immune System in Huma... J Pharmacol Exp Ther 2004
Schruers K, Griez E The effects of tianeptine or paroxetine on 35 CO2 provoked panic in pa... J Psychopharmacol 2004
Segura M, Farre M, Pichin... Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetami... Clin Pharmacokinet 2005
Chipana C, Camarasa J, Pu... Memantine prevents MDMA-induced neurotoxicity Neurotoxicology 2008
Izzo AA, Ernst E Interactions between herbal medicines and prescribed drugs: an updated... Drugs 2009
Martínez-Clemente J, Escu... Interaction of mephedrone with dopamine and serotonin targets in rats Eur Neuropsychopharm... 2011
Schoenfuss HL, Furlong ET... Complex mixtures, complex responses: Assessing pharmaceutical mixtures... Environ Toxicol Chem 2015
Mitchell-Mata C, Thomas B... Two Fatal Intoxications Involving 3-Methoxyphencyclidine J Anal Toxicol 2017